✦ LIBER ✦

Amyloid-modifying therapies for Alzheimer’s disease: therapeutic progress and its implications

✍ Scribed by Meaghan C. Creed; Norton W. Milgram

Publisher: Springer Netherlands
Year: 2010
Tongue: English
Weight: 331 KB
Volume: 32
Category: Article
ISSN: 0161-9152
DOI: 10.1007/s11357-010-9142-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cognitive reserve and its implications f

Cognitive reserve and its implications for rehabilitation and Alzheimer’s disease

✍ Giulia Liberati; Antonino Raffone; Marta Olivetti Belardinelli 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 216 KB

Amino acids variations in Amyloid-β pept

Amino acids variations in Amyloid-β peptides, mitochondrial dysfunction, and new therapies for Alzheimer’s disease

✍ Hani Atamna 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 200 KB

APOLIPOPROTEIN E IS ASSOCIATED WITH ISLE

APOLIPOPROTEIN E IS ASSOCIATED WITH ISLET AMYLOID AND OTHER AMYLOIDOSES: IMPLICATIONS FOR ALZHEIMER'S DISEASE

✍ CHARGÉ, SOPHIE B. P.; ESIRI, MARGARET M.; BETHUNE, CLAIRE A.; HANSEN, BARBARA C. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 652 KB

Apolipoprotein E (ApoE) has recently been proposed as an aetiological factor of Alzheimer's disease (AD): ApoE is co-localized to amyloid plaques and neurofibrillary tangles in the brain and binds to AP-protein in vitvo. An association of ApoE e4 allele with the development of AD has been reported.

Microglial interaction with β-amyloid: I

Microglial interaction with β-amyloid: Implications for the pathogenesis of Alzheimer's disease

✍ Maria E. Bamberger; Gary E. Landreth 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

## Abstract The etiology of Alzheimer's disease (AD) involves a significant inflammatory component as evidenced by the presence of elevated levels of a diverse range of proinflammatory molecules in the AD brain. These inflammatory molecules are produced principally by activated microglia, which are

Translational medicine perspective in de

Translational medicine perspective in development of disease modifying therapies for Alzheimer's disease: biomarkers to buy down the risk

✍ Hong I. Wan; Orest Hurko; Mark Day; J. Lynn Rutkowski 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 2 views

Peripheral reduction of β-amyloid is suf

Peripheral reduction of β-amyloid is sufficient to reduce brain β-amyloid: Implications for Alzheimer's disease

✍ J. Gregor Sutcliffe; Peter B. Hedlund; Elizabeth A. Thomas; Floyd E. Bloom; Bria 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB

Three loci that modify β-amyloid (Aβ) accumulation and deposition in the brains of a mouse model of Alzheimer's disease have been previously described. One encompasses the Psen2 gene encoding presenilin 2, a component of the γ-secretase activity responsible for generating Aβ by proteolysis. We show